CLINICAL_TRIALS
trial_result
· 2017-07-11
Clinical Trial Update: A Study of Anthrax Vaccines Px563L and RPA563 in Healthy Adult Subjects [Phase 1]
Summary
This Phase 1 trial of anthrax vaccines Px563L and RPA563 in healthy adults has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfenex, Inc | Conditions: Anthrax | Phase 1 | Status: COMPLETED